FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022852589> ?p ?o ?g. }

• W2022852589 endingPage "245" @default.
• W2022852589 startingPage "235" @default.
• W2022852589 abstract "The management of pregnancy in Philadelphia negative chronic myeloproliferative disorders (CMPDs) is an increasingly frequent problem. In the literature, most pregnancies are reported for women with essential thrombocythemia (ET) with about 400 pregnancies in about 200 women. In ET, first trimester abortion is the most frequent complication occurring in about one third of pregnancies. Interestingly, the incidence of maternal complications is relatively low with 3% for major thromboembolic and 2% for major bleeding events. The presence of the Jak2 mutation seems to be an independent predictor of pregnancy complications. Pregnancies in ET should be stratified according to underlying risk factors in low, high and highest risk pregnancies. Women with low risk pregnancies are treated with low-dose aspirin, whereas women with high and higher risk pregnancies may benefit from low-dose aspirin plus interferon alpha ± low molecular weight heparin throughout pregnancy and at least for six weeks post-partum. In polycythemia vera (PV) there is only very few information on pregnancy outcome with 36 pregnancies reported in the literature. According to these data pregnancy in PV is per se a high risk situation. Accordingly, all women with PV should be treated with low-dose aspirin. Some pregnant PV patients may benefit from a more intensive therapy including interferon alpha ± low molecular weight heparin throughout pregnancy and at least for six weeks post-partum." @default.
• W2022852589 created "2016-06-24" @default.
• W2022852589 creator A5006360930 @default.
• W2022852589 creator A5069072959 @default.
• W2022852589 creator A5074936860 @default.
• W2022852589 date "2008-09-01" @default.
• W2022852589 modified "2023-10-16" @default.
• W2022852589 title "Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy" @default.
• W2022852589 cites W1978463385 @default.
• W2022852589 cites W1997944331 @default.
• W2022852589 cites W1998984328 @default.
• W2022852589 cites W2000892733 @default.
• W2022852589 cites W2008968623 @default.
• W2022852589 cites W2019963889 @default.
• W2022852589 cites W2022054499 @default.
• W2022852589 cites W2024839136 @default.
• W2022852589 cites W2052905336 @default.
• W2022852589 cites W2058960147 @default.
• W2022852589 cites W2059903100 @default.
• W2022852589 cites W2066099140 @default.
• W2022852589 cites W2070592326 @default.
• W2022852589 cites W2071788667 @default.
• W2022852589 cites W2073933360 @default.
• W2022852589 cites W2075295588 @default.
• W2022852589 cites W2076967176 @default.
• W2022852589 cites W2080968939 @default.
• W2022852589 cites W2081173173 @default.
• W2022852589 cites W2081295057 @default.
• W2022852589 cites W2082121080 @default.
• W2022852589 cites W2093493529 @default.
• W2022852589 cites W2093828693 @default.
• W2022852589 cites W2121310716 @default.
• W2022852589 cites W2126665281 @default.
• W2022852589 cites W2132430173 @default.
• W2022852589 cites W2136099689 @default.
• W2022852589 cites W2145308085 @default.
• W2022852589 cites W2154289682 @default.
• W2022852589 cites W2159962994 @default.
• W2022852589 cites W4234642826 @default.
• W2022852589 cites W4249380055 @default.
• W2022852589 doi "https://doi.org/10.1016/j.blre.2008.03.007" @default.
• W2022852589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18617299" @default.
• W2022852589 hasPublicationYear "2008" @default.
• W2022852589 type Work @default.
• W2022852589 sameAs 2022852589 @default.
• W2022852589 citedByCount "59" @default.
• W2022852589 countsByYear W20228525892012 @default.
• W2022852589 countsByYear W20228525892013 @default.
• W2022852589 countsByYear W20228525892014 @default.
• W2022852589 countsByYear W20228525892015 @default.
• W2022852589 countsByYear W20228525892016 @default.
• W2022852589 countsByYear W20228525892017 @default.
• W2022852589 countsByYear W20228525892018 @default.
• W2022852589 countsByYear W20228525892019 @default.
• W2022852589 countsByYear W20228525892020 @default.
• W2022852589 countsByYear W20228525892021 @default.
• W2022852589 countsByYear W20228525892022 @default.
• W2022852589 countsByYear W20228525892023 @default.
• W2022852589 crossrefType "journal-article" @default.
• W2022852589 hasAuthorship W2022852589A5006360930 @default.
• W2022852589 hasAuthorship W2022852589A5069072959 @default.
• W2022852589 hasAuthorship W2022852589A5074936860 @default.
• W2022852589 hasConcept C120665830 @default.
• W2022852589 hasConcept C121332964 @default.
• W2022852589 hasConcept C126322002 @default.
• W2022852589 hasConcept C131872663 @default.
• W2022852589 hasConcept C2776884760 @default.
• W2022852589 hasConcept C2777218350 @default.
• W2022852589 hasConcept C2777557582 @default.
• W2022852589 hasConcept C2777628954 @default.
• W2022852589 hasConcept C2778642596 @default.
• W2022852589 hasConcept C2778837598 @default.
• W2022852589 hasConcept C2779234561 @default.
• W2022852589 hasConcept C2781057849 @default.
• W2022852589 hasConcept C29456083 @default.
• W2022852589 hasConcept C54355233 @default.
• W2022852589 hasConcept C61511704 @default.
• W2022852589 hasConcept C71924100 @default.
• W2022852589 hasConcept C86803240 @default.
• W2022852589 hasConceptScore W2022852589C120665830 @default.
• W2022852589 hasConceptScore W2022852589C121332964 @default.
• W2022852589 hasConceptScore W2022852589C126322002 @default.
• W2022852589 hasConceptScore W2022852589C131872663 @default.
• W2022852589 hasConceptScore W2022852589C2776884760 @default.
• W2022852589 hasConceptScore W2022852589C2777218350 @default.
• W2022852589 hasConceptScore W2022852589C2777557582 @default.
• W2022852589 hasConceptScore W2022852589C2777628954 @default.
• W2022852589 hasConceptScore W2022852589C2778642596 @default.
• W2022852589 hasConceptScore W2022852589C2778837598 @default.
• W2022852589 hasConceptScore W2022852589C2779234561 @default.
• W2022852589 hasConceptScore W2022852589C2781057849 @default.
• W2022852589 hasConceptScore W2022852589C29456083 @default.
• W2022852589 hasConceptScore W2022852589C54355233 @default.
• W2022852589 hasConceptScore W2022852589C61511704 @default.
• W2022852589 hasConceptScore W2022852589C71924100 @default.
• W2022852589 hasConceptScore W2022852589C86803240 @default.
• W2022852589 hasIssue "5" @default.
• W2022852589 hasLocation W20228525891 @default.

• next